NMRA - Neumora Therapeutics Sotuvning sof marjinal rentabelligi

neumoratx.com (NMRA) - korporativ logo

Prognoz qilingan savdo marjalari klinik sinovlar bosqichi tufayli barqaror daromadning yo'qligini ko'rsatmoqda, bunda ko'rsatkich qiymati 0.00 ni tashkil etadi. Neumora Therapeutics (NMRA) kompaniyasining aniq psixiatriya sohasidagi yuqori nufuzi AI asosidagi dori vositalarini kashf qilish platformasi bilan ta'minlanadi. Hozirgi vaqtda kompaniya o'zining pipeline mahsulotlarining organik rivojlanishiga tayanib, faqat ilmiy institutlar bilan tadqiqot ittifoqlarini tuzmoqda.

Neumora Corp (NMRA) Sof foyda normasi: 21.02.2024 - 20.11.2026 davri uchun

Neumora Therapeutics Inc (NMRA) kompaniyasining tahliliy kesimlari

- aksiya kursi va ekspertlarning narx prognozi:
Kompaniyaning har tomonlama tahlili:neumoratx.com, NMRA
Neumora ishlab chiqargan mahsulot

Ushbu ko'rsatkich sof foydaning tushumga nisbati sifatida hisoblanadi va barcha xarajatlar chegirilgandan keyin biznesning operatsion daromadni yakuniy kapitalga aylantirish qobiliyatini belgilaydi. Neumora Therapeutics (NMRA) uchun dori vositalari ta'sir mexanizmlarining diversifikatsiyasi haddan tashqari ko'p miqdordagi hisobdan chiqarishlar xavfini kamaytiradi, bu esa neyropsixiatrik terapiyalarni ishlab chiqishda xarajatlarni boshqarishning real samaradorligini bashorat qilinadigan savdo marjalari orqali kuzatish imkonini beradi.

Raqobatchilar tahlili

BIIB: Sotuvning sof marjinal rentabelligi|Sof marja Neurocrine Biosciences Inc (NBIX)|RGC (Regencell Corp) - Sotuvning sof marjinal rentabelligi|AXSM: Sof foyda normasi|Sof marja acadia-pharm.com (ACAD)|Sotuvning sof marjinal rentabelligi Xenon Pharmaceuticals (XENE)|Sof marja Viking Therapeutics VKTX|Sof foyda normasi SUPN|CPRX - Sof marja|Sof marja Denali Therapeutics|HRMY: Sotuvning sof marjinal rentabelligi|Biohaven - Sof foyda normasi|Sof foyda bo'yicha sotuv rentabelligi AMLX|Trevi Therapeutics, Inc. (TRVI) - Kompaniya sotuv marjasi|Sof foyda bo'yicha sotuv rentabelligi PRAX (Praxis Medicines)|Anavex Corp - Sotuvning sof rentabelligi|Sof marja CeriBell CBLL|Kompaniya sotuv marjasi Prothena Biosciences (PRTA)|ALEC: Sof foyda bo'yicha sotuv rentabelligi|ANNX - Sotuvning sof marjinal rentabelligi|Omeros Corp. (OMER) - Sof marja|Sof marja Neurogene Inc. (NGNE)|Sof foyda bo'yicha sotuv rentabelligi ACIU|Sof marja VYGR|Sof foyda bo'yicha sotuv rentabelligi SCLX (Scilex Holding Company, Inc.)|Sof marja TVGN (Tevogen Bio)|Sof marja Alpha Cognition ACOG|CGTX - Sof foyda bo'yicha sotuv rentabelligi|IKT - Sof marja|SAVA: Sof marja|Assertio Therapeutics (ASRT) - Sof marja|Sof marja Coya Therapeutics Inc (COYA)|Sof marja Vistagen|Sotuvning sof rentabelligi OVID (ovidrx.com)|Sof marja Acumen Pharmaceuticals, Inc. (ABOS)|CRVO - Sof marja|Alterity Therapeutics Ltd. - Sof foyda bo'yicha sotuv rentabelligi|CLNN - Sof foyda bo'yicha sotuv rentabelligi|PEPG - Sof marja|Kompaniya sotuv marjasi jupiterneurosciences.com JUNS|Relmada Therapeutics (RLMD) - Sof marja|ANVS (Annovis Bio, Inc.) - Sof marja|Sof marja gracetx.com|Sotuvning sof marjinal rentabelligi Firefly Neuroscience, Inc.|Sof marja ANEW Medical (KLTO)|NRSN - Sof marja|Sotuvning sof marjinal rentabelligi RVPH (Reviva Pharmaceuticals Holdings Inc.)|Kompaniyaning sof rentabelligi MTVA (metaviatx.com)|NeurAxis Inc. - Sotuvning sof marjinal rentabelligi|Kompaniya sotuv marjasi heliusmedical.com HSDT|PASG: Sotuvning sof marjinal rentabelligi|Neuphoria - Sof foyda normasi|Sof foyda bo'yicha sotuv rentabelligi NERV|ATHA: Sof foyda normasi|Sof marja Addex Therapeutics Ltd (ADXN)|ALZN (Alzamend Neuro Inc.) - Sof foyda normasi|Sotuvning sof marjinal rentabelligi CYCN (cyclerion.com)|Sof foyda bo'yicha marjinallik Protagenic|KTTA: Sof foyda bo'yicha sotuv rentabelligi|Sof foyda normasi CRGT (cortigent.com)|ATXI: Sotuvning sof marjinal rentabelligi|BCLI (BrainStorm Cell Therapeutics) - Sof marja|CARA (Cara Therapeutics Inc.) - Sotuvning sof marjinal rentabelligi|Sof marja CHRO|Sof foyda bo'yicha sotuv rentabelligi ELYM (Eliem Therapeutics)|Sof marja ITCI (Intra-Cellular Therapies Inc.)|Sotuvning sof marjinal rentabelligi LBPH (Longboard Pharma)|Sotuvning sof marjinal rentabelligi Marinus Pharmaceuticals Inc MRNS|NKGen Biotech Corp - Sotuvning sof marjinal rentabelligi|Sof foyda normasi NRBO (NeuroBo Pharma)|SAGE (Sage Therapeutics, Inc) - Sof foyda bo'yicha sotuv rentabelligi|Sotuvning sof rentabelligi SNPX|Sof foyda bo'yicha sotuv rentabelligi TRVN|Sof marja VIGL|Sotuvning sof marjinal rentabelligi WENA|Kompaniya sotuv marjasi Cerevel